Hong, Y A <br/><br/>
Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection.  [electronic resource] 

 -  Transplantation proceedings  Jan 2012 
 - 182-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2011.12.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Biopsy<br/>Chronic Disease<br/>Drug Therapy, Combination<br/>Female<br/>Graft Rejection--diagnosis<br/>HLA Antigens--immunology<br/>Humans<br/>Immunity, Humoral--drug effects<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Isoantibodies--blood<br/>Kidney Transplantation--immunology<br/>Male<br/>Proteinuria--drug therapy<br/>Republic of Korea<br/>Rituximab<br/>Time Factors<br/>Treatment Outcome